Advertisement

Index by Author

December 1994; 43 (12)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Alvarsson, M

    • Glucose potentiation of arginine-induced insulin secretion is impaired in subjects with a glucokinase Glu256Lys mutation. Diabetes December 1994 43:1402-1406; doi:10.2337/diabetes.43.12.1402

  2. Arrigoni-Martelli, E

    • Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine. Diabetes December 1994 43:1469-1477; doi:10.2337/diabetes.43.12.1469

B

  1. Bain, S C

    • Parental origin of diabetes-associated HLA types in sibling pairs with type I diabetes. Diabetes December 1994 43:1462-1468; doi:10.2337/diabetes.43.12.1462

  2. Balasse, E O

    • Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM. Diabetes December 1994 43:1418-1425; doi:10.2337/diabetes.43.12.1418

  3. Barnett, A H

    • Parental origin of diabetes-associated HLA types in sibling pairs with type I diabetes. Diabetes December 1994 43:1462-1468; doi:10.2337/diabetes.43.12.1462

  4. Baskin, D G

    • Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes December 1994 43:1457-1461; doi:10.2337/diabetes.43.12.1457

  5. Bhatti, S

    • Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes December 1994 43:1494-1499; doi:10.2337/diabetes.43.12.1494

  6. Bowsher, R R

    • Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes December 1994 43:1490-1493; doi:10.2337/diabetes.43.12.1490

C

  1. Chang, K C

    • Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine. Diabetes December 1994 43:1469-1477; doi:10.2337/diabetes.43.12.1469

  2. Chen, Y D

    • Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM. Diabetes December 1994 43:1440-1444; doi:10.2337/diabetes.43.12.1440

  3. Clarke, W L

    • Individual differences in neurobehavioral disruption during mild and moderate hypoglycemia in adults with IDDM. Diabetes December 1994 43:1407-1412; doi:10.2337/diabetes.43.12.1407

  4. Connell, J M

    • Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM. Dissociation of metabolic and blood pressure effects. Diabetes December 1994 43:1445-1449; doi:10.2337/diabetes.43.12.1445

  5. Corr, P B

    • Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine. Diabetes December 1994 43:1469-1477; doi:10.2337/diabetes.43.12.1469

  6. Cox, D J

    • Individual differences in neurobehavioral disruption during mild and moderate hypoglycemia in adults with IDDM. Diabetes December 1994 43:1407-1412; doi:10.2337/diabetes.43.12.1407

  7. Cryer, P E

    • Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes December 1994 43:1426-1434; doi:10.2337/diabetes.43.12.1426

D

  1. D'Alessio, D A

    • Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes December 1994 43:1457-1461; doi:10.2337/diabetes.43.12.1457

  2. Dagogo-Jack, S

    • Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes December 1994 43:1426-1434; doi:10.2337/diabetes.43.12.1426

  3. Dillon, T

    • Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes December 1994 43:1494-1499; doi:10.2337/diabetes.43.12.1494

  4. Donnelly, R

    • Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM. Dissociation of metabolic and blood pressure effects. Diabetes December 1994 43:1445-1449; doi:10.2337/diabetes.43.12.1445

  5. Driesen, N R

    • Individual differences in neurobehavioral disruption during mild and moderate hypoglycemia in adults with IDDM. Diabetes December 1994 43:1407-1412; doi:10.2337/diabetes.43.12.1407

  6. Dyrberg, T

    • Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes December 1994 43:1478-1484; doi:10.2337/diabetes.43.12.1478

E

  1. Efendic, S

    • Glucose potentiation of arginine-induced insulin secretion is impaired in subjects with a glucokinase Glu256Lys mutation. Diabetes December 1994 43:1402-1406; doi:10.2337/diabetes.43.12.1402

  2. Efrat, S

    • Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes December 1994 43:1413-1417; doi:10.2337/diabetes.43.12.1413

  3. Ege, E A

    • Active and passive mechanical properties of isolated arterioles from STZ-induced diabetic rats. Effect of aminoguanidine treatment. Diabetes December 1994 43:1450-1456; doi:10.2337/diabetes.43.12.1450

  4. Elliott, H L

    • Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM. Dissociation of metabolic and blood pressure effects. Diabetes December 1994 43:1445-1449; doi:10.2337/diabetes.43.12.1445

  5. Elliott, J F

    • Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes December 1994 43:1494-1499; doi:10.2337/diabetes.43.12.1494

  6. Ensinck, J W

    • Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes December 1994 43:1457-1461; doi:10.2337/diabetes.43.12.1457

F

  1. Ferrell, R E

    • ApoA-IV polymorphism associated with myocardial infarction in obese NIDDM patients. The San Luis Valley Diabetes Study. Diabetes December 1994 43:1485-1489; doi:10.2337/diabetes.43.12.1485

  2. Féry, F

    • Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM. Diabetes December 1994 43:1418-1425; doi:10.2337/diabetes.43.12.1418

  3. Fiore, D M

    • Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes December 1994 43:1413-1417; doi:10.2337/diabetes.43.12.1413

  4. Fleischer, N

    • Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes December 1994 43:1413-1417; doi:10.2337/diabetes.43.12.1413

  5. Fuh, M M

    • Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM. Diabetes December 1994 43:1440-1444; doi:10.2337/diabetes.43.12.1440

  6. Fusco-DeMane, D

    • Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes December 1994 43:1413-1417; doi:10.2337/diabetes.43.12.1413

G

  1. Gao, K M

    • Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes December 1994 43:1435-1439; doi:10.2337/diabetes.43.12.1435

  2. Gavin, J R, 3rd

    • Good news in diabetes. Diabetes December 1994 43:1391-1393

  3. Gingerich, R

    • Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes December 1994 43:1490-1493; doi:10.2337/diabetes.43.12.1490

  4. Glaser, A

    • Glucose potentiation of arginine-induced insulin secretion is impaired in subjects with a glucokinase Glu256Lys mutation. Diabetes December 1994 43:1402-1406; doi:10.2337/diabetes.43.12.1402

  5. Gonder-Frederick, L A

    • Individual differences in neurobehavioral disruption during mild and moderate hypoglycemia in adults with IDDM. Diabetes December 1994 43:1407-1412; doi:10.2337/diabetes.43.12.1407

  6. Grill, V

    • Glucose potentiation of arginine-induced insulin secretion is impaired in subjects with a glucokinase Glu256Lys mutation. Diabetes December 1994 43:1402-1406; doi:10.2337/diabetes.43.12.1402

H

  1. Haffner, S M

    • Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes December 1994 43:1490-1493; doi:10.2337/diabetes.43.12.1490

  2. Hamman, R F

    • ApoA-IV polymorphism associated with myocardial infarction in obese NIDDM patients. The San Luis Valley Diabetes Study. Diabetes December 1994 43:1485-1489; doi:10.2337/diabetes.43.12.1485

  3. Hazuda, H P

    • Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes December 1994 43:1490-1493; doi:10.2337/diabetes.43.12.1490

  4. Hegre, O D

    • Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes December 1994 43:1413-1417; doi:10.2337/diabetes.43.12.1413

  5. Hill, M A

    • Active and passive mechanical properties of isolated arterioles from STZ-induced diabetic rats. Effect of aminoguanidine treatment. Diabetes December 1994 43:1450-1456; doi:10.2337/diabetes.43.12.1450

  6. Hoagland, V

    • Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes December 1994 43:1457-1461; doi:10.2337/diabetes.43.12.1457

  7. Hoag, S

    • ApoA-IV polymorphism associated with myocardial infarction in obese NIDDM patients. The San Luis Valley Diabetes Study. Diabetes December 1994 43:1485-1489; doi:10.2337/diabetes.43.12.1485

I

  1. Ido, Y

    • Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine. Diabetes December 1994 43:1469-1477; doi:10.2337/diabetes.43.12.1469

J

  1. Jeng, C Y

    • Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM. Diabetes December 1994 43:1440-1444; doi:10.2337/diabetes.43.12.1440

K

  1. Kahn, S E

    • Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes December 1994 43:1457-1461; doi:10.2337/diabetes.43.12.1457

  2. Kamboh, M I

    • ApoA-IV polymorphism associated with myocardial infarction in obese NIDDM patients. The San Luis Valley Diabetes Study. Diabetes December 1994 43:1485-1489; doi:10.2337/diabetes.43.12.1485

  3. Karlsen, A E

    • Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes December 1994 43:1478-1484; doi:10.2337/diabetes.43.12.1478

  4. Khoursheed, M

    • Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes December 1994 43:1435-1439; doi:10.2337/diabetes.43.12.1435

  5. Kilo, C

    • Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine. Diabetes December 1994 43:1469-1477; doi:10.2337/diabetes.43.12.1469

  6. Knaack, D

    • Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes December 1994 43:1413-1417; doi:10.2337/diabetes.43.12.1413

L

  1. Laurance, M

    • Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes December 1994 43:1413-1417; doi:10.2337/diabetes.43.12.1413

  2. Lauzon, J

    • Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes December 1994 43:1494-1499; doi:10.2337/diabetes.43.12.1494

  3. Lee, M K

    • Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes December 1994 43:1435-1439; doi:10.2337/diabetes.43.12.1435

  4. Leiser, M

    • Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes December 1994 43:1413-1417; doi:10.2337/diabetes.43.12.1413

  5. Luthman, H

    • Glucose potentiation of arginine-induced insulin secretion is impaired in subjects with a glucokinase Glu256Lys mutation. Diabetes December 1994 43:1402-1406; doi:10.2337/diabetes.43.12.1402

M

  1. Markholst, H

    • Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes December 1994 43:1478-1484; doi:10.2337/diabetes.43.12.1478

  2. McHowat, J

    • Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine. Diabetes December 1994 43:1469-1477; doi:10.2337/diabetes.43.12.1469

  3. Michelsen, B

    • Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes December 1994 43:1478-1484; doi:10.2337/diabetes.43.12.1478

  4. Miles, P D

    • Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes December 1994 43:1435-1439; doi:10.2337/diabetes.43.12.1435

  5. Mitchell, B D

    • Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes December 1994 43:1490-1493; doi:10.2337/diabetes.43.12.1490

  6. Moller, D E

    • Transgenic approaches to the pathogenesis of NIDDM. Diabetes December 1994 43:1394-1401; doi:10.2337/diabetes.43.12.1394

  7. Monterossa, A

    • Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes December 1994 43:1490-1493; doi:10.2337/diabetes.43.12.1490

  8. Moossa, A R

    • Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes December 1994 43:1435-1439; doi:10.2337/diabetes.43.12.1435

  9. Morris, A D

    • Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM. Dissociation of metabolic and blood pressure effects. Diabetes December 1994 43:1445-1449; doi:10.2337/diabetes.43.12.1445

  10. Mykkänen, L

    • Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes December 1994 43:1490-1493; doi:10.2337/diabetes.43.12.1490

O

  1. Olefsky, J M

    • Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes December 1994 43:1435-1439; doi:10.2337/diabetes.43.12.1435

  2. Orfalian, Z

    • Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine. Diabetes December 1994 43:1469-1477; doi:10.2337/diabetes.43.12.1469

P

  1. Palmiter, R D

    • Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes December 1994 43:1457-1461; doi:10.2337/diabetes.43.12.1457

  2. Petersen, J S

    • Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes December 1994 43:1478-1484; doi:10.2337/diabetes.43.12.1478

  3. Petrie, J R

    • Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM. Dissociation of metabolic and blood pressure effects. Diabetes December 1994 43:1445-1449; doi:10.2337/diabetes.43.12.1445

Q

  1. Qin, H Y

    • Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes December 1994 43:1494-1499; doi:10.2337/diabetes.43.12.1494

R

  1. Rattarasarn, C

    • Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes December 1994 43:1426-1434; doi:10.2337/diabetes.43.12.1426

  2. Reaven, G M

    • Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM. Diabetes December 1994 43:1440-1444; doi:10.2337/diabetes.43.12.1440

  3. Rewers, M

    • ApoA-IV polymorphism associated with myocardial infarction in obese NIDDM patients. The San Luis Valley Diabetes Study. Diabetes December 1994 43:1485-1489; doi:10.2337/diabetes.43.12.1485

  4. Rowe, B R

    • Parental origin of diabetes-associated HLA types in sibling pairs with type I diabetes. Diabetes December 1994 43:1462-1468; doi:10.2337/diabetes.43.12.1462

  5. Ryan, C M

    • Individual differences in neurobehavioral disruption during mild and moderate hypoglycemia in adults with IDDM. Diabetes December 1994 43:1407-1412; doi:10.2337/diabetes.43.12.1407

S

  1. Shetterly, S M

    • ApoA-IV polymorphism associated with myocardial infarction in obese NIDDM patients. The San Luis Valley Diabetes Study. Diabetes December 1994 43:1485-1489; doi:10.2337/diabetes.43.12.1485

  2. Sheu, W H

    • Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM. Diabetes December 1994 43:1440-1444; doi:10.2337/diabetes.43.12.1440

  3. Singh, B

    • Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes December 1994 43:1494-1499; doi:10.2337/diabetes.43.12.1494

  4. Singh, R K

    • Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes December 1994 43:1494-1499; doi:10.2337/diabetes.43.12.1494

  5. Small, M

    • Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM. Dissociation of metabolic and blood pressure effects. Diabetes December 1994 43:1445-1449; doi:10.2337/diabetes.43.12.1445

  6. Smith, D K

    • Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes December 1994 43:1494-1499; doi:10.2337/diabetes.43.12.1494

  7. Stern, M P

    • Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes December 1994 43:1490-1493; doi:10.2337/diabetes.43.12.1490

  8. Surana, M

    • Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes December 1994 43:1413-1417; doi:10.2337/diabetes.43.12.1413

T

  1. Todd, J A

    • Parental origin of diabetes-associated HLA types in sibling pairs with type I diabetes. Diabetes December 1994 43:1462-1468; doi:10.2337/diabetes.43.12.1462

U

  1. Ueda, S

    • Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM. Dissociation of metabolic and blood pressure effects. Diabetes December 1994 43:1445-1449; doi:10.2337/diabetes.43.12.1445

V

  1. Valdez, R A

    • Proinsulin and specific insulin concentration in high- and low-risk populations for NIDDM. Diabetes December 1994 43:1490-1493; doi:10.2337/diabetes.43.12.1490

  2. Verchere, C B

    • Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes December 1994 43:1457-1461; doi:10.2337/diabetes.43.12.1457

W

  1. Wajngot, A

    • Glucose potentiation of arginine-induced insulin secretion is impaired in subjects with a glucokinase Glu256Lys mutation. Diabetes December 1994 43:1402-1406; doi:10.2337/diabetes.43.12.1402

  2. Williamson, J R

    • Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine. Diabetes December 1994 43:1469-1477; doi:10.2337/diabetes.43.12.1469

  3. Worsaae, A

    • Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes December 1994 43:1478-1484; doi:10.2337/diabetes.43.12.1478

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement